Amyloid-beta-targeted monoclonal antibodies probably resulted in little to no difference in cognitive function or in dementia severity.

Early myocarditis onset may predict treatment-related fatality in patients receiving immune checkpoint inhibitor therapy.

Findings based on national survey of adults visiting an emergency department. HealthDay News — Substantial gaps in adult ...

HealthDay News — Intralesional nivolumab seems effective for reducing the size of precancerous oral lesions, according to a study presented at the annual meeting of the American Association for Cancer ...